chevron_leftBack
As of 13 June 2026, PROCEPT BioRobotics Corp. has a market cap of $1.24B USD, ranking #9518 globally and #2029 in the United States.
It ranks #818 in the Healthcare sector, and #165 in the Medical Devices industry.
Key Stats
Market Cap
$1.24BUSD
Enterprise Value
$1.03BUSD
Revenue (TTM)
$308.05MUSD
EBITDA (TTM)
-$97.47MUSD
Net Income (TTM)
-$95.57MUSD
EBITDA Margin
-32%
Profit Margin
-31%
PS Ratio
4.0
PB Ratio
3.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Larry Wood
open_in_new
Employees
888
Founded
2009
IPO
15 Sep 2021
Website
procept-biorobotics.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -5.7% | -14% | -18% | -28% | -41% | -60% |
News
Loading...
PRCT Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
PRCT
PROCEPT BioRobotics Corp
ISIN: US74276L1052
Shares Out.:
Shares Outstanding:
56.919M1
Shares Float:
54.716M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
21.71 USD | |
|
PRCT
PROCEPT BioRobotics Corp
ISIN: US74276L1052
|
431.50 MXN |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About PROCEPT BioRobotics Corp.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
14K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
13K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
13K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
10K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
10K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
7K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
8K%
|
22.2
|
|
EPA: EL
|
$97.46B
8K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$61.41B
5K%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.47B
4K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.38B
3K%
28.99B CHF
|
37.9
|
|
|
$30.06B
2K%
203.66B CNY
|
26.0
|
chevron_leftBack